EcoDrugPlus

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSELUG00000015146
Gene Symbol: HTR4
3 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine Receptor 5a

Ensembl ID : ENSELUG00000006032
Gene Symbol: HTR5A
3 Cross references
215 Possible Orthologues:

5-Hydroxytryptamine Receptor 7

Ensembl ID : ENSELUG00000030806
Gene Symbol: HTR7
3 Cross references
152 Possible Orthologues:

5-Hydroxytryptamine Receptor 7

Ensembl ID : ENSELUG00000015297
Gene Symbol: LOC105008655
2 Cross references
197 Possible Orthologues:

60s Ribosomal Protein L10a

Ensembl ID : ENSELUG00000007032
Gene Symbol: LOC105016832
4 Cross references
375 Possible Orthologues:

60s Ribosomal Protein L19

Ensembl ID : ENSELUG00000006332
Gene Symbol: LOC105008443
3 Cross references
348 Possible Orthologues:

60s Ribosomal Protein L19

Ensembl ID : ENSELUG00000017052
Gene Symbol: LOC105013308
3 Cross references
355 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSELUG00000003077
Gene Symbol: LOC105013892
3 Cross references
383 Possible Orthologues:

60s Ribosomal Protein L26

Ensembl ID : ENSELUG00000024894
Gene Symbol: LOC105024418
3 Cross references
477 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSELUG00000018807
Gene Symbol: LOC105008943
3 Cross references
338 Possible Orthologues:

60s Ribosomal Protein L35

Ensembl ID : ENSELUG00000001990
Gene Symbol: LOC105014154
3 Cross references
251 Possible Orthologues:

60s Ribosomal Protein L37

Ensembl ID : ENSELUG00000034681
Gene Symbol: LOC105014087
3 Cross references
425 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).